Insiders · PHIO

PHIO insider transactions

Phio Pharmaceuticals Corp. (PHIO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PHIO

• 78d
  Director Lockshin Curtis was granted 16,600 shares, increasing direct ownership by 89% to 35,155 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 78d
  Director Freeman Jonathan E was granted 16,600 shares, increasing direct ownership by 103% to 32,655 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 78d
  Director Deming David H was granted 23,800 shares, increasing direct ownership by 170% to 37,800 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 78d
  Chief Financial Officer Carson Lisa Cabott was granted 47,000 shares, increasing direct ownership by 100% to 94,000 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 78d
  Director Bradford Patricia A was granted 18,500 shares, increasing direct ownership by 68% to 45,651 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 78d
  Chairman, Pres. & CEO Bitterman Robert J was granted 120,000 shares, increasing direct ownership by 41% to 411,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 113d
  Chairman, Pres. & CEO Bitterman Robert J bought $5,150 worth of shares (5,000 units at $1.03), increasing direct ownership by 2% to 291,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 117d
  Chairman, Pres. & CEO Bitterman Robert J bought $5,100 worth of shares (5,000 units at $1.02), increasing direct ownership by 2% to 286,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 152d
  Chairman, Pres. & CEO Bitterman Robert J bought $5,700 worth of shares (5,000 units at $1.14), increasing direct ownership by 2% to 281,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 157d
  Chairman, Pres. & CEO Bitterman Robert J bought $6,350 worth of shares (5,000 units at $1.27), increasing direct ownership by 2% to 276,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  Amendment: Director Ferrara Robert L was granted 23,100 shares, increasing direct ownership by 147% to 38,766 units (SEC Form 4)

  4/A - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  Director Deming David H was granted 14,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  Director Lockshin Curtis was granted 16,200 shares, increasing direct ownership by 688% to 18,555 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  Director Freeman Jonathan E was granted 14,700 shares, increasing direct ownership by 1,085% to 16,055 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  Director Ferrara Robert L was granted 23,000 shares, increasing direct ownership by 147% to 38,666 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  VP, Finance and Administration Carson Lisa Cabott was granted 47,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  Director Bradford Patricia A was granted 18,800 shares, increasing direct ownership by 225% to 27,151 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 222d
  Chairman, Pres. & CEO Bitterman Robert J covered exercise/tax liability with 4,111 shares and was granted 250,000 shares, increasing direct ownership by 963% to 271,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 311d
  SEC Form 3 filed by new insider Carson Lisa Cabott

  3 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 318d
  Chairman, Pres & CEO Bitterman Robert J bought $4,840 worth of shares (2,000 units at $2.42), increasing direct ownership by 8% to 27,149 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 318d
  Director Ferrara Robert L bought $6,050 worth of shares (2,500 units at $2.42), increasing direct ownership by 19% to 15,666 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 319d
  Chairman, Pres & CEO Bitterman Robert J bought $4,125 worth of shares (1,500 units at $2.75), increasing direct ownership by 6% to 25,149 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 337d
  Chairman, Pres & CEO Bitterman Robert J bought $7,446 worth of shares (4,200 units at $1.77), increasing direct ownership by 22% to 23,649 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 339d
  Director Ferrara Robert L bought $4,550 worth of shares (2,500 units at $1.82), increasing direct ownership by 23% to 13,166 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 417d
  SEC Form 3 filed by new insider Deming David H

  3 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 589d
  VP, CFO Infarinato Robert M. was granted 3,000 shares, increasing direct ownership by 38% to 11,000 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 589d
  Director Freeman Jonathan E was granted 1,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 589d
  Chairman, Pres & CEO Bitterman Robert J was granted 15,500 shares, increasing direct ownership by 665% to 17,832 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 590d
  Director Lockshin Curtis was granted 2,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 590d
  Director Ferrara Robert L was granted 10,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 590d
  Director Bradford Patricia A was granted 8,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 618d
  VP, Chief Financial Officer Infarinato Robert M. was granted 8,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 624d
  SEC Form 3 filed by new insider Infarinato Robert M.

  3 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 683d
  President & CEO Bitterman Robert J bought $740 worth of shares (1,000 units at $0.74), increasing direct ownership by 5% to 20,990 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 684d
  President & CEO Bitterman Robert J bought $750 worth of shares (1,000 units at $0.75), increasing direct ownership by 5% to 19,990 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 781d
  Kontulis Caitlin covered exercise/tax liability with 335 shares, decreasing direct ownership by 3% to 10,643 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 788d
  Bitterman Robert J bought $2,275 worth of shares (2,500 units at $0.91), increasing direct ownership by 15% to 18,990 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 793d
  Bitterman Robert J covered exercise/tax liability with 1,804 shares, decreasing direct ownership by 10% to 16,490 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 795d
  Kontulis Caitlin covered exercise/tax liability with 1,181 shares, decreasing direct ownership by 10% to 10,978 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 935d
  Bitterman Robert J covered exercise/tax liability with 917 shares, decreasing direct ownership by 5% to 18,294 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1025d
  SEC Form 4 filed by Bitterman Robert J

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1045d
  SEC Form 4 filed by Ferrara Robert L

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Lockshin Curtis was granted 1,500 shares, increasing direct ownership by 88% to 3,197 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Freeman Jonathan E was granted 1,500 shares, increasing direct ownership by 88% to 3,197 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Ferrara Robert L was granted 1,500 shares, increasing direct ownership by 60% to 4,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Cauwenbergh Geert was granted 1,500 shares, increasing direct ownership by 55% to 4,235 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Bradford Patricia A was granted 1,500 shares, increasing direct ownership by 90% to 3,167 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Kontulis Caitlin was granted 4,500 shares, increasing direct ownership by 56% to 12,494 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Bitterman Robert J was granted 11,000 shares, increasing direct ownership by 177% to 17,211 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1163d
  SEC Form 4: Kontulis Caitlin covered exercise/tax liability with 657 shares, decreasing direct ownership by 8% to 7,994 units to satisfy withholding tax

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1227d
  SEC Form 4: Bitterman Robert J bought $780 worth of shares (2,000 units at $0.39), increasing direct ownership by 3% to 74,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1234d
  SEC Form 4: Bitterman Robert J bought $780 worth of shares (2,000 units at $0.39), increasing direct ownership by 3% to 72,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1236d
  SEC Form 4: Bitterman Robert J bought $860 worth of shares (2,000 units at $0.43), increasing direct ownership by 3% to 70,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1237d
  SEC Form 4: Ferrara Robert L bought $2,041 worth of shares (5,000 units at $0.41), increasing direct ownership by 20% to 30,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1243d
  SEC Form 4: Bitterman Robert J bought $1,136 worth of shares (2,715 units at $0.42), increasing direct ownership by 4% to 68,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1244d
  SEC Form 4: Ferrara Robert L bought $820 worth of shares (2,000 units at $0.41), increasing direct ownership by 9% to 25,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1256d
  SEC Form 4: Bitterman Robert J bought $1,750 worth of Series D Preferred Stock (1 units at $1,750.00)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1300d
  SEC Form 4: Bitterman Robert J was granted 40,000 shares, increasing direct ownership by 155% to 65,826 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1307d
  SEC Form 4: Bradford Patricia A was granted 20,000 shares

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1457d
  SEC Form 3 filed by new insider Bradford Patricia A

  3 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)